Anti-Human Tissue Factor Antibody Helps Lung Injury in Mice
Author Information
Author(s): He Xiaolin, Han Bing, Mura Marco, Li Li, Cypel Marcelo, Soderman Avery, Picha Kristen, Yang Jing, Liu Mingyao
Primary Institution: University Health Network Toronto General Research Institute, University of Toronto
Hypothesis
Can a humanized anti-tissue factor monoclonal antibody reduce acute lung injury in a mouse model?
Conclusion
The anti-hTF antibody significantly reduced lung injury caused by intestinal ischemia-reperfusion in mice.
Supporting Evidence
- The anti-hTF mAb reduced lung injury scores significantly.
- Treatment with CNTO859 decreased total cell counts in bronchoalveolar lavage fluid.
- The antibody reduced alveolar fibrin deposition and inflammatory responses.
Takeaway
Researchers found that a special antibody can help protect mice's lungs from damage after a surgery that cuts off blood flow to the intestines.
Methodology
The study used human tissue factor knock-in mice and administered a humanized anti-tissue factor monoclonal antibody to assess its effects on lung injury.
Limitations
The study was limited by the availability of a humanized IgG for comparison.
Participant Demographics
Male hTF-KI mice aged 6-8 weeks, weighing 25-30 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website